CR
Curis, Inc.
CRIS · NASDAQ
$0.83 -7.55% (-$0.07)
1M -44.30%
Market Cap $1.62M
P/E Ratio -
Div. Yield -
ROE 1,035.26%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/S 0.37x
P/B 0.34x
P/E N/A
Growth
6 /100
Declining Rev. growth 2.42%
Book val. growth 51.04%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 99.28%
Net margin 490.33%
Op. margin 833.40%
Quality
3 /100
Poor ROIC 567.17%
ROE 1,035.26%
ROA 111.51%
Debt
69 /100
Low Debt/Equity 0.22x
Current ratio 0.49x
Int. coverage N/A
Stability
42 /100
Moderate Beta 3.00x
Rev. volatility 11.14%
EPS volatility 38.63%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRIS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Dentzer
Employees
22
Headquarters
Lexington
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report